-
-
-
-
-
-
-
Xeris Pharmaceuticals (XERS) Revises 2022 Outlook Upwards
-
-
-
-
-
-
-
Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events
-
-
-
-
-
-
-
Aerami Therapeutics Appoints Barry Deutsch as Chief Financial Officer
-
-
-
-
-
-
-
Xeris Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
-
-
-
-
-
-
-
Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris
-
-
-
-
-
-
-
Xeris Pharmaceuticals Achieves Unprecedented Levels of Payor Coverage for Gvoke®
-
-
-
-
-
-
-
Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

